Sosnowski Robert Edward 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed May 6, 2010
Insider Transaction Report
Form 4
Sosnowski Robert Edward
VP, Marketing & Sales
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value per share
2010-05-04$0.44/sh+10,000$4,400→ 10,000 total - Exercise/Conversion
Option
2010-05-04−10,000→ 90,000 totalExercise: $0.44From: 2009-11-18Exp: 2018-11-18→ Common Stock (10,000 underlying) - Sale
Common Stock, $0.001 par value per share
2010-05-04$2.50/sh−10,000$25,000→ 0 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Sosnowski.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers on November 18, 2008.
- [F3]23,333 of these options vested on November 18, 2009, the first anniversary of the grant date, and the balance of the options vest ratably on a monthly basis over the following 24 months.